placebo implant

DRUG3 trials

Sponsors

University of Pennsylvania, Titan Pharmaceuticals, RTI International

Conditions

AcceptabilityHeroin DependenceOpioid DependencyOpioid-Related Disorders

Phase 2

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

CompletedNCT00218426

University of PennsylvaniaHeroin Dependence, Opioid-Related Disorders

Start: 2006-07-31End: 2010-11-04Updated: 2019-03-18

Phase 3

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

CompletedNCT01114308

Titan PharmaceuticalsOpioid Dependency

Start: 2010-04-30End: 2011-05-31Updated: 2018-12-31

Unknown Phase

South African Male User Research on Acceptability of Implants and Injections

CompletedNCT05139563

RTI InternationalAcceptability

Start: 2022-07-12End: 2024-08-01Updated: 2025-04-06